IT'S TIME FOR UNIVERSAL HEALTH CARE

georgeob1 wrote:

Instead, if they do not consent to the government's terms they are faced with a Canadian prohibition of sales in the country and, in many cases, action by the Canadian government to authorize Canadian production of generic substitutes for patented drugs.

A really interesting report shows e.g. that in the USA are quite more generics sold than in Canada.

Generally, generiss are internationally only allowed after the patents expired. Are you really certain that the Canadian government sponsors illegal acts and even without legal action by the patent holders?

And speaking about patents (and trademarks): the USA doesn't consider Aspirin® to be a trademark ....

When I was in the military back in the late fifties, that's what we called it, "acetylsalicylic acid," instead of aspirin.

Spending on direct-to-consumer drug advertising in the United States rose by a staggering 330 per cent in the first decade after drug companies were freed to pitch their wares directly to the public, rising to just under $30 billion for the year 2005, a new study shows.

The work, published in Thursday's issue of the New England Journal of Medicine, revealed that new ad campaigns typically start within a year of a drug's arrival on the market - a time when it has been suggested that drug companies should not be allowed to advertise a drug.

Earlier this year a report published by the U.S. Institute of Medicine recommended that the American drug regulator, the Food and Drug Administration, bar drug companies from advertising prescription drugs in the first two years after they come to market. It is during that period when a drug first starts to be broadly used that rare side-effects not seen in clinical trials can become evident.

"Our data show that a mandatory waiting period on advertising for new drugs would represent a dramatic departure from current industry practices," wrote the authors, from the University of Pittsburgh, Harvard School of Public Health and Vanderbilt School of Medicine in Nashville, Tenn.

if you are wondering where some of the money drug companies are spending goes , have a look at the link below .
hbg

Quote:

Spending on direct-to-consumer drug advertising in the United States rose by a staggering 330 per cent in the first decade after drug companies were freed to pitch their wares directly to the public, rising to just under $30 billion for the year 2005, a new study shows.

The work, published in Thursday's issue of the New England Journal of Medicine, revealed that new ad campaigns typically start within a year of a drug's arrival on the market - a time when it has been suggested that drug companies should not be allowed to advertise a drug.

Earlier this year a report published by the U.S. Institute of Medicine recommended that the American drug regulator, the Food and Drug Administration, bar drug companies from advertising prescription drugs in the first two years after they come to market. It is during that period when a drug first starts to be broadly used that rare side-effects not seen in clinical trials can become evident.

"Our data show that a mandatory waiting period on advertising for new drugs would represent a dramatic departure from current industry practices," wrote the authors, from the University of Pittsburgh, Harvard School of Public Health and Vanderbilt School of Medicine in Nashville, Tenn.

full report :
SPENDING ON DRUG ADVERTISING SOARS !

Bayer A.G., the West German drug and chemical group, said it had paid Sterling Drug Inc. $25 million to buy back partial rights to its Bayer trademark in the United States, ending a prohibition dating from the end of World War I. Sterling will continue to sell aspirin under Bayer's name and symbol in North America. Bayer bought the right to use the trademark on industrial products such as plastics and organic and inorganic chemicals. Bayer, which invented aspirin at the end of the last century, will still be barred from selling consumer products and pharmaceuticals under its own name in the United States.

SPIRIN 325 mg TABLETS MICRO-COATED WHITE 1000s
NDC: 00536-3305-10
*Compare to: Bayer®, Genuine, a registered trademark of Bayer AG

The product information presented here is intended for use in the United States only. Countries outside the United States may have different regulatory requirements and review practices that may require referencing different or additional information.

The U.S. Prescribing Information in this product database represents the current product labeling information as of the date of the document.

Evidently, the drug companies are showering physicians with payola. Recently, a specialist told me that he wouldn't be able to make it absent this.

The four girls were born at a US hospital because there was no space available at Canadian neonatal intensive care units.

Health officials said they checked every other neonatal intensive care unit in Canada but none had space.

Tell me something...

If the US healthcare system is so bad,and if systems like the Canadian system are so good,why does a woman come to Montana from Canada to give birth??

Why werent there enough beds in the Canadian healthcare system for this woman?

Why is that?

Report shows fewer than 1 in 4 Canadian MDs use electronic records to keep track of patients

There are only 29 per 1 million university graduates with advanced research qualifications in health and life sciences compared with an average of 60 per 1 million for the top 10 OECD countries examined. And our universities have lower invention disclosures, patent applications and patents granted.

The report noted there was little collaboration between universities and businesses. Business enterprises fund about 10 per cent of the research performed in Ontario's universities, it stated.

Our researchers do love to publish. In 2005, Canadians produced 714 published articles per 1 million capita, compared with 527 per 1 million, the average for the other OECD comparator countries.

No time? That's too bad, when one considers all the free medical literature the reps provide.

perhaps you'd like to leave some information and he can contact you when he has some time ! " .